Episode 18: Karen Petrou and David Brint - BioBonds

Episode 18 March 23, 2022 00:55:46
Episode 18: Karen Petrou and David Brint - BioBonds
Few & Far Between: Conversations from the Front Lines of Drug Development
Episode 18: Karen Petrou and David Brint - BioBonds

Mar 23 2022 | 00:55:46

/

Show Notes

On this week’s Few & Far Between podcast episode, Biorasi’s CEO, Chris O'Brien, welcomes Karen Petrou and David Brint for an in-depth discussion on BioBonds and how they can jumpstart funding in clinical research for rare disease and other disorders.

Other Episodes

Episode 12

October 13, 2021 00:46:48
Episode Cover

Episode 12: Effie Parks and Spela Mirosevic

Social media platforms and podcasts are spotlighting the untold stories of rare disease patients and their families. Find out more in today's Few &...

Listen

Episode 36

December 05, 2023 00:51:43
Episode Cover

Episode 36: Zak Kohane, Department of Biomedical Informatics at Harvard Medical School

"Patients have already been exposed to these large language models (LLMs). Yes, they are aware of the risks, but they are also very aware...

Listen

Episode 7

August 04, 2021 00:38:14
Episode Cover

Episode 7: US Congressman Gus Bilirakis

On today's podcast, US Congressman Gus Bilirakis joins host Wayne Bowden to discuss the importance of rare disease awareness and treatment.

Listen